Newcastle Clinical Trials Unit

Staff Profile

Nicola Goudie

Trial Manager

Background

I am a Trial Manager within the Newcastle Clinical Trials Unit (NCTU). I currently work on the following clinical Trials: 

  • EMesis in Pregnancy - Ondansetron With mEtoclopRamide (EMPOWER)

  • A randomised, double-blind, placebo controlled trial of pramipexole in addition to mood stabilisers for patients with treatment resistant bipolar depression (PAX-BD)

  • Long-term Safety and Efficacy Study of Deferiprone in Patients with Pantothenate Kinase-Associated Neurodegeneration (PKAN) (TIRCON2012V1-EXT)

  • A randomized, double-blind, placebo-controlled trial of deferiprone in patients with pantothenate kinase-associated neurodegeneration (PKAN) (TIRCON2012V1) 

As a Trial Manager I support researchers with the set-up, monitoring and close-down of single-centre and multi-centre research trials. During my time at NCTU I have worked on a variety of trial types including CTIMP and Surgical trials. I have also worked on trials based within a variety of clinical specialties.

I have worked at NCTU since December 2014, starting as an Assistant Trial Manager before progressing to Trial Manger in June 2015. Prior to working within the NCTU I worked within the R&D Departments at The Newcastle upon Tyne Hospitals NHS Foundation Trust and Tees, Esk and Wear Valleys NHS Foundation Trust. I have worked in research since December 2009.

Since October 2013 I have also held the role of GCP Facilitator within the North East and North Cumbria LCRN. As a GCP Facilitator I am involved in the delivery of GCP Training courses to staff involved in research across the North East and North Cumbria region.

 

Research

Current Trials: 

  • EMesis in Pregnancy - Ondansetron With mEtoclopRamide (EMPOWER)

  • A randomised, double-blind, placebo controlled trial of pramipexole in addition to mood stabilisers for patients with treatment resistant bipolar depression (PAX-BD)

  • Long-term Safety and Efficacy Study of Deferiprone in Patients with Pantothenate Kinase-Associated Neurodegeneration (PKAN) (TIRCON2012V1-EXT)

  • A randomized, double-blind, placebo-controlled trial of deferiprone in patients with pantothenate kinase-associated neurodegeneration (PKAN) (TIRCON2012V1)

 Previous Trials: 

  • Preoperative Behavioural Intervention to Reduce Drinking before elective orthopaedic Surgery (PRE-OP BIRDS)

  • The National Trial of Tonsillectomy in Adults: a clinical and cost effectiveness study (NATTINA)

  • Effect of folic acid supplementation in pregnancy on preeclampsia - Folic Acid Clinical Trial (FACT)

  • A Randomized Controlled Trial of Intensive Versus Standard Physical Rehabilitation Therapy in the Critically Ill (Extra Physiotherapy In Critical Care) (EPICC)

  • A randomised controlled pilot trial of Losartan as an anti-fibrotic agent in non-alcoholic steatohepatitis (anti-Fibrotic Effects of Losartan In NASH Evaluation study) (FELINE)

 

Publications